Tesamorelin

Tesamorelin — Stabilised GHRH Analogue Research Peptide

Tesamorelin is a synthetic 44-amino acid analogue of naturally occurring Growth Hormone-Releasing Hormone (GHRH), developed with enhanced stability and resistance to enzymatic degradation. It is widely studied in laboratory settings for its interaction with growth hormone signalling pathways, IGF-1 regulation, and metabolic research models.

Supplied in high-purity lyophilised form, Tesamorelin is commonly utilised in in vitro and pre-clinical research investigating endocrine signalling, pulsatile growth hormone release mechanisms, and metabolic pathway biology.

Research Areas of Interest

• Growth Hormone-Releasing Hormone (GHRH) pathway research
• Growth hormone secretion studies
• IGF-1 signalling investigations
• Endocrine and metabolic pathway research
• Visceral adipose tissue biology studies
• Pituitary receptor interaction research

Research Use Only

This product is supplied strictly for laboratory, analytical, and research purposes only. It is not intended for human consumption, veterinary use, diagnosis, treatment, or prevention of any disease. All research must be conducted by appropriately qualified personnel in controlled laboratory environments.

For Research Use Only. Not for Human or Animal Consumption. Genesis Research Co.

Legal & Safety Information

This product is supplied strictly for laboratory research purposes only. It is not intended for human consumption, medical use, or any form of therapeutic application.

Genesis Research Co. does not promote or condone the use of this product outside of controlled research environments.

By purchasing, the customer acknowledges that they are responsible for ensuring compliance with all applicable laws and regulations within their jurisdiction.

Products are supplied in sealed vials and should be handled using appropriate laboratory protocols.